Halozyme Therapeutics | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
Acadia Pharmaceuticals USD 732.79M 155.61M 2024-12
Agios Pharmaceuticals USD 1.54B 85.72M 2024-12
Alnylam Pharmaceuticals USD 67.09M 34.73M 2024-12
Amarin USD 531.38M 20.5M 2024-09
Amgen USD 5.88B 1.65B 2024-12
Baxter International USD 6.96B 908M 2024-12
Cytokinetics USD -135372000 121.46M 2024-12
DBV Technologies USD 54.03M 25.06M 2024-09
Eli Lilly USD 14.19B 47.9M 2024-12
Halozyme Therapeutics USD 363.82M 88.88M 2024-12
Indivior -167000000 46M 2024-09
Intra Cellular Therapies USD 1.15B 3.63M 2024-12
Ionis Pharmaceuticals USD 588.35M 74.12M 2024-12
MannKind USD -78816000 131.11M 2024-12
Pfizer USD 88.2B 4.08B 2024-12
United Therapeutics USD 6.44B 343.1M 2024-12



Halozyme Therapeutics Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.